CHICAGO, Jan. 24, 2013 (GLOBE NEWSWIRE) -- Merge Healthcare Incorporated (Nasdaq:MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that Tampa General Hospital selected Merge's CTMS for Investigators solution for enterprise-wide management of its clinical trials.
Tampa General Hospital's goal was to increase efficiency and centralize their business operations. They sought a CTMS to manage more than 500 active studies annually across all therapeutic areas, and track study activities for over 100 study coordinators. Billing compliance, financial accountability, patient and enrollment tracking, and reporting for management oversight were all important criteria in selecting a CTMS system.
"With the continued growth of clinical trial activities, we needed a better way to streamline data collection and reporting, as well as a more accurate method for tracking billing activities. We had previously relied on data collected in spreadsheets and multiple databases, and a time-consuming process to produce reports," said Beth Kohl, Manager, Office of Clinical Research at Tampa General Hospital. "We sought a CTMS that would centralize and organize our research operations to replace numerous manual and fragmented methods of capturing and recording data. After evaluating several CTMS systems, we felt that Merge CTMS provided us the standardization needed, as well as the reporting capabilities to meet our compliance, study and patient tracking, enrollment metrics, and financial requirements."The ability for the CTMS to integrate with an existing electronic medical record (EMR) system was also a priority for Tampa General Hospital, so users could have easy access to study patients from a centralized database used throughout the hospital. "Another important factor in our decision was Merge's vast systems integration experience," continued Kohl. "A key component of this project will be an HL7 integration, allowing us to feed data from our Epic EMR into Merge CTMS. Through enhanced patient study searches and the elimination of duplicate data entry, this integration will yield significant efficiency improvement for research operations."
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV